Advertisement

Reactions Weekly

, Volume 1730, Issue 1, pp 235–235 | Cite as

Nivolumab

Various toxicities: 5 case reports
Case report
  • 12 Downloads

Reference

  1. Takeda T, et al. Neutrophil-to-lymphocyte ratio after four weeks of nivolumab administration as a predictive marker in patients with pretreated non-small-cell lung cancer. Thoracic Cancer 9: 1291-1299, No. 10, Oct 2018. Available from: URL: http://doi.org/10.1111/1759-7714.12838 - Japan

Copyright information

© Springer Nature Switzerland AG 2018

Personalised recommendations